Pediatric Nephrology

, Volume 28, Issue 6, pp 919–925 | Cite as

Impact of platelet transfusions in children with post-diarrheal hemolytic uremic syndrome

  • Alejandro Balestracci
  • Sandra Mariel Martin
  • Ismael Toledo
  • Caupolican Alvarado
  • Raquel Eva Wainsztein
Original Article

Abstract

Background

Platelet transfusions should be avoided in children with post-diarrheal hemolytic uremic syndrome (D + HUS) because they might increase microthrombi formation, thereby aggravating the disease. As this possibility has not yet been explored, we investigated whether platelet transfusion in patients with D + HUS would lead to a worse disease course compared to that in patients who did not receive platelet transfusion.

Methods

This was a case–control study in which data from D + HUS children who received platelet transfusions (cases, n  =  23) and those who did not (controls, n  =  54) were retrospectively reviewed and compared.

Results

Both patient groups were similar in age (p = 0.3), gender (p  =  0.53), weight (p  =  0.86), height (p  =  0.45), prior use of non-steroidal anti-inflammatory drugs (p  =  0.59) or antibiotics (p  =  0.45) and presence of dehydration at admission (p  =  0.79). The two groups also did not differ in initial leukocyte count (p  =  0.98), hematocrit (p  =  0.44) and sodium (p  =  0.11) and alanine aminotransferase levels (p  =  0.11). During hospitalization, dialysis duration (p  =  0.08), number of erythrocyte transfusions (p  =  0.2), serum creatinine peak (p  =  0.22), presence of severe bowel (p  =  0.43) or neurologic (p  =  0.97) injury, arterial hypertension (p  =  0.71), need for intensive care (p  =  0.33) and death (p  =  1.00) were also comparable.

Conclusion

Our findings suggest that platelet transfusion does not aggravate the course of the disease. Conversely, no hemorrhagic complications were observed in the group of patients who did not receive a platelet transfusion. Until these observations are confirmed by further studies, the benefits and risk of platelet transfusion should be thoughtfully balanced on an individual case basis.

Keywords

Hemolytic uremic syndrome Thrombocytopenia Platelet transfusion Acute kidney injury Clinical outcome 

References

  1. 1.
    Scheiring J, Andreoli SP, Zimmerhackl LB (2008) Treatment and outcome of Shiga-toxin-associated Hemolytic Uremic Syndrome (HUS). Pediatr Nephrol 23(10):1749–1760PubMedCrossRefGoogle Scholar
  2. 2.
    Scheiring J, Rosales A, Zimmerhackl LB (2010) Clinical practice. Today’s understanding of the haemolytic uraemic syndrome. Eur J Pediatr 169(1):7–13PubMedCrossRefGoogle Scholar
  3. 3.
    Tarr PI (2009) Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis. Kidney Int 75[Suppl 112]:S29–S32CrossRefGoogle Scholar
  4. 4.
    Tarr PI, Gordon CA, Chandler WL (2005) Shiga-toxin-producing Escherichia coli and haemolytic uremic syndrome. Lancet 365(9464):1073–1086PubMedGoogle Scholar
  5. 5.
    Chandler WL, Jelacic S, Boster DR, Ciol MA, Williams GD, Watkins SL, Igarashi T, Tarr PI (2002) Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome. N Engl J Med 346(1):23–32PubMedCrossRefGoogle Scholar
  6. 6.
    Seltz LB, Bakel LA, Tiehen J, Gao D, Cadnapaphornchai MA, Lum G, Ford D (2012) Efficacy and safety of clopidogrel in children with diarrhea associated hemolytic uremic syndrome. Thromb Res 130(3):e26–e30PubMedCrossRefGoogle Scholar
  7. 7.
    Ray P, Liu XH (2001) Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome. Pediatr Nephrol 16:823–839PubMedCrossRefGoogle Scholar
  8. 8.
    Zoja C, Buelli S, Morigi M (2010) Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction. Pediatr Nephrol 25:2231–2240PubMedCrossRefGoogle Scholar
  9. 9.
    Keir L, Coward RJ (2011) Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy. Pediatr Nephrol 26(4):523–533PubMedCrossRefGoogle Scholar
  10. 10.
    Tsai M, Kita A, Leach J, Rounsevell R, Huang JN, Moake J, Ware RE, Fletcher DA, Lam WA (2012) In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. J Clin Invest 122(1):408–418PubMedCrossRefGoogle Scholar
  11. 11.
    Petruzziello TN, Mawji IA, Khan M, Marsden PA (2009) Verotoxin biology: molecular events in vascular endothelial injury. Kidney Int 75[Suppl 112]:S17–S19CrossRefGoogle Scholar
  12. 12.
    Gallo EG, Gianantonio CA (1995) Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome. Pediatr Nephrol 9(1):117–119PubMedCrossRefGoogle Scholar
  13. 13.
    Iijima K, Kamioka I, Nozu K (2008) Management of diarrhea-associated hemolytic uremic syndrome in children. Clin Exp Nephrol 12(1):16–19PubMedCrossRefGoogle Scholar
  14. 14.
    Karpman D, Papadopoulou D, Nilsson K, Sjögren AC, Mikaelsson C, Lethagen S (2001) Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome. Blood 97(10):3100–3108PubMedCrossRefGoogle Scholar
  15. 15.
    Weil BR, Andreoli SP, Billmire DF (2010) Bleeding risk for surgical dialysis procedures in children with hemolytic uremic syndrome. Pediatr Nephrol 25(9):1693–1698PubMedCrossRefGoogle Scholar
  16. 16.
    American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies (2006) Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 105:198–208CrossRefGoogle Scholar
  17. 17.
    Development Task Force of the College of American Pathologists, (1994) Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. Fresh-frozen plasma, cryoprecipitate, and platelets administration practice guidelines development task force of the College of American Pathologists. JAMA 271:777–781CrossRefGoogle Scholar
  18. 18.
    Spizzirri FD, Rahman RC, Bibiloni N, Ruscasso J, Amoreo O (1997) Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and pronostic features. Pediatr Nephrol 11(2):156–160PubMedCrossRefGoogle Scholar
  19. 19.
    Caletti MG, Gallo G, Gianantonio CA (1996) Development of focal segmental sclerosis and hyalinosis in hemolytic uremic syndrome. Pediatr Nephrol 10:687–692PubMedCrossRefGoogle Scholar
  20. 20.
    Balestracci A, Martin SM, Toledo I, Alvarado C, Wainsztein RE (2012) Dehydration at admission increased the need for dialysis in hemolytic uremic syndrome children. Pediatr Nephrol 27(8):1407–1410PubMedCrossRefGoogle Scholar
  21. 21.
    Walters MD, Matthei IU, Kay R, Dillon MJ, Barratt TM (1989) The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome. Pediatr Nephrol 3(2):130–134PubMedCrossRefGoogle Scholar
  22. 22.
    Oakes R, Siegler R, McReynolds M, Pysher T, Pavia A (2006) Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics 117(5):1656–1662PubMedCrossRefGoogle Scholar
  23. 23.
    Coad N, Marshall T, Rowe B, Taylor CM (1991) Changes in the postenteropathic form of the hemolytic uremic syndrome in children. Clin Nephrol 35(1):10–16PubMedGoogle Scholar
  24. 24.
    Kamioka I, Yoshiya K, Satomura K, Kaito H, Fujita T, Iijima K, Nakanishi K, Yoshikawa N, Nozu K, Matsuo M, Japanese Society for Pediatric Nephrology (2008) Risk factors for developing severe clinical course in HUS patients: a national survey in Japan. Pediatr Int 50(4):441–446PubMedCrossRefGoogle Scholar
  25. 25.
    Nathanson S, Kwon T, Elmaleh M, Charbit M, Launay EA, Harambat J, Brun M, Ranchin B, Bandin F, Cloarec S, Bourdat-Michel G, Piètrement C, Champion G, Ulinski T, Deschênes G (2010) Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 5:1218–1228PubMedCrossRefGoogle Scholar
  26. 26.
    Rahman RC, Cobeñas CJ, Drut R, Amoreo O, Ruscasso J, Spizzirri A, Suarez A, Zalba J, Ferrari C, Gatti M (2012) Hemorrhagic colitis in postdiarrheal hemolytic uremic syndrome: retrospective analysis of 54 children. Pediatr Nephrol 27(2):229–233PubMedCrossRefGoogle Scholar
  27. 27.
    de Buys Roessingh AS, de Lagausie P, Baudoin V, Loirat C, Aigrain Y (2007) Gastrointestinal complications of post-diarrheal hemolytic uremic syndrome. Eur J Pediatr Surg 17(5):328–334PubMedCrossRefGoogle Scholar
  28. 28.
    National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114[Suppl 2]:S555–S576Google Scholar
  29. 29.
    Hanley JA, Lippman-Hand A (1983) If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA 249(13):1743–1745PubMedCrossRefGoogle Scholar
  30. 30.
    Wong CS, Mooney JC, Brandt JR, Staples AO, Jelacic S, Boster DR, Watkins SL, Tarr PI (2012) Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis 55(1):33–41PubMedCrossRefGoogle Scholar
  31. 31.
    Andreoli SP (2009) Acute kidney injury in children. Pediatr Nephrol 24(2):253–263PubMedCrossRefGoogle Scholar
  32. 32.
    Bell BP, Griffin PM, Lozano P, Christie DL, Kobayashi JM, Tarr PI (1997) Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 100(1):E12PubMedCrossRefGoogle Scholar
  33. 33.
    Grisaru S, Morgunov MA, Samuel SM, Midgley JP, Wade AW, Tee JB, Hamiwka LA (2011) Acute renal replacement therapy in children with diarrhea-associated hemolytic uremic syndrome: a single center 16 years of experience. Int J Nephrol 2011:930539PubMedGoogle Scholar
  34. 34.
    Oh G, Lau KK (2011) Characteristics of children with sporadic hemolytic uremic syndrome in a single Northern California center. Int Urol Nephrol 44(5):1467–1472PubMedCrossRefGoogle Scholar
  35. 35.
    Lumbreras Fernández J, Cruz Rojo J, Iñigo Martín G, Muley Alonso R, Vara Martín J (2010) Hemolytic uremic syndrome: long term renal injury. An Pediatr (Barc) 72(5):309–316CrossRefGoogle Scholar
  36. 36.
    Matsell DG, White CT (2009) An outbreak of diarrhea-associated childhood hemolytic uremic syndrome: the Walkerton epidemic. Kidney Int 75[Suppl 112]:S35–S37CrossRefGoogle Scholar

Copyright information

© IPNA 2013

Authors and Affiliations

  • Alejandro Balestracci
    • 1
    • 2
  • Sandra Mariel Martin
    • 1
  • Ismael Toledo
    • 1
  • Caupolican Alvarado
    • 1
  • Raquel Eva Wainsztein
    • 1
  1. 1.Nephrology UnitHospital General de Niños Pedro de ElizaldeCiudad Autónoma de Buenos AiresArgentina
  2. 2.Unidad de Nefrología Hospital General de Niños Pedro de ElizaldeBuenos AiresArgentina

Personalised recommendations